Menu
GWAS Study

Uniting biobank resources reveals novel genetic pathways modulating susceptibility for atopic dermatitis.

Sliz E, Huilaja L, Pasanen A et al.

34454985 PubMed ID
GWAS Study Type
796661 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

SE
Sliz E
HL
Huilaja L
PA
Pasanen A
LT
Laisk T
RE
Reimann E
MR
Mägi R
HK
Hannula-Jouppi K
PS
Peltonen S
ST
Salmi T
KL
Koulu L
TK
Tasanen K
KJ
Kettunen J
Chapter II

Abstract

Summary of the research findings

Atopic dermatitis (AD) is a common chronic inflammatory skin disease with high heritability. Previous genome-wide association studies have identified several loci predisposing to AD. These findings explain approximately 30% of the variance in AD susceptibility, suggesting that further work is required to fully understand the genetic underpinnings.

22,474 European ancestry cases, 774,187 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

796661
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
Finland, U.K., Estonia
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.